, using data derived from a study of 225 men with testicular cancer, calculated that having a first degree relative with testicular cancer was associated with a 6-fold elevated risk in comparison with the general population. There has been relatively little research into whether the excess in familial cases occurs as a result of a genetic predisposition, common environment or both (Gedde-Dahl et al., 1985; Dieckmann et al., 1987; Forman, 1989; Oliver, 1990) .
There are numerous reports in the literature of families where two or more first degree relatives have been diagnosed with germ cell tumours of the testis. To date at least 21 pairs of identical twins, 82 sets of brothers (other than identical twins) and 31 father-son pairs have been reported (Weissbach & Widman, 1986; Dieckmann et al., 1987 and references therein; Dieckmann & Keyserlingk, 1989 and references therein; Goss & Bulbul, 1990; Patel et al., 1990) . Only one attempt has been made to estimate the risk of testicular cancer in men who have an affected first degree relative. Tollerud et al. (1985) , using data derived from a study of 225 men with testicular cancer, calculated that having a first degree relative with testicular cancer was associated with a 6-fold elevated risk in comparison with the general population. There has been relatively little research into whether the excess in familial cases occurs as a result of a genetic predisposition, common environment or both (Gedde-Dahl et al., 1985; Dieckmann et al., 1987; Forman, 1989; Oliver, 1990) .
We have established a UK-based register for familial testicular cancer to provide a means for the systematic documentation of new cases, including histological verification, and for obtaining standardised lymphocyte-DNA samples from affected and unaffected family members for subsequent genetic linkage analysis. In this paper we describe data on the first 42 families reported to the register for which confirmation of the diagnosis has been obtained.
A sub-set of these families were identified from interviews about family history with men diagnosed as having testicular cancer for whom an age-matched control was also interviewed. Using these families, it was possible to estimate the There have been a number of studies (De Wolf et al., 1979; Majsky, 1979; Pollack et al., 1982; Oliver et al., 1986a,b; Dieckmann & Keyserlingk, 1988; Kratzik et al., 1989) which show that patients with testicular cancer have a different distribution of histocompatibility antigens (HLA) compared with control populations. Because of this, it has been suggested that disease susceptibility may be partly influenced by a gene within, or closely linked to, the HLA complex on chromosome 6 (Oliver et al., 1986a,b) . We have, therefore, conducted a sib-pair analysis (Haseman & Elston, 1972; Thomson & Bodmer, 1976) (Bodmer, 1982) .
Methods
Case ascertainment Familial cases of testicular cancer were mainly identified as a result of a general mailing to consultants in oncology and radiotherapy throughout the UK. Subsequent to the mailing, further families were notified to the register on an ad-hoc basis. Another source of cases arose from structured interviews with men participating in a national population-based case-control study of testicular cancer (full details of which will be published elsewhere). These men had been diagnosed with testicular cancer between 1984 and 1986 and were aged 15 to 49 years at diagnosis. All men within this age range who were resident in any of eight predefined geographical areas (each within a different Regional Health Authority) were eligible for entry into the study, with the exception of those in non-white caucasian racial groups and those mentally unable to participate in an interview. In total 863 men were eligible for entry, of whom 794 (92%) completed an interview. Relative risk estimation
The prevalence of testicular cancer among first-degree relatives (i.e. fathers and brothers) of the 794 cases participating in the case-control study was used to estimate the size of familial risk. An initial comparison was made with the prevalence of testicular cancer among the 794 control men interviewed in the same study. These men were selected at random from the list of the general practitioner with whom the case was registered and were matched ( ± 1 year) for age. Any reports of relatives with testicular cancer were followed up and had to be confirmed by a histopathology report in order to be included in the comparison. A matched casecontrol analysis (Breslow & Day, 1980 ) to estimate relative risk was then carried out. Case-control analysis is, however, extremely imprecise. This is partly because of the small number of affected relatives, especially in the control group (see Results), and partly because it does not fully take account of the number of brothers at risk or the length of time for which they are at risk. An additional estimate of the risk to brothers was, therefore, obtained by actuarial anaylsis (Peto et al., 1976) . Person years were calculated for all brothers of cases from their birth to the date of interview of the case or to prior death of the brother. This then enabled the calculation of a cumulative risk for a brother developing testicular cancer by a given age. This risk was then compared with the equivalent population risk calculated from England and Wales National Cancer Registration Scheme data for the year 1985 (OPCS, 1990 ).
Blood preparation and HLA typing Blood (25 ml) was taken into bottles containing 0.33% Trisodium Citrate and 0.5 AM Mercaptoethanol, in RPMI 1640
Hepes buffered medium. Lymphocytes for HLA typing were prepared by centrifugation over a Lymphoprep (Nyegaard) density gradient, and HLA typed according to the method of Bodmer and Bodmer (1979) , using a panel of locally available antisera. Haplotypes were assigned by HLA typing of parents and sibs and looking at the patterns of antigen inheritance. This allowed for the determination of haplotype sharing between affected sibs. In some cases it was not possible to estimate unambiguously the number of shared haplotypes because either one parent was homozygous or one parent was not tested and could potentially have been homozygous. The observed distribution of haplotype sharing was compared with that expected on the basis of mendelian segregation and tested with a chi-square statistic (Thomson & Bodmer, 1976) . Where there was ambiguity about the number of shared haplotypes an assumption of maximum sharing was made solely for the purposes of this analysis. One sibship, for which the HLA typing has been reported previously (and partly gave rise to the hypothesis under consideration), was excluded from the initial analysis.
Reported identical twins were checked for monozygosity by southern blotting with mini-satellite probes (R. Hawkins, personal communication.
Results

Description offamilies
In total, 42 families with two or more members diagnosed with testicular cancer had been reported to us or identified by us by March 1991. Details of the cases in these families are listed in Table I . Three of these families (nos. 10, 39, 42) have been previously reported (Oliver et al., 1986b) . Table I shows, for each case, the age at diagnosis, the side and histological classification of the tumour and whether or not the patient had a history of undescended testis (UDT). Twelve families that were identified through the national case-control study, and were used in the risk estimates, are also indicated.
In Table I , there are two pairs of identical twins, 27 sets of other brothers (including one pair of half brothers), nine father-son pairs, two pairs of first cousins and two unclenephew pairs. There are four families where one brother of a pair has had bilateral testicular cancer (family nos. 1, 2, 19, 20) and there is one such father (family no. 31). There are also two sibships of three affected brothers (family nos. 7, 10).
There are 91 tumours described in Table I present in 86 individuals in the 42 families, five patients having had bilateral disease. Of the 91 tumours, 42 have been categorised by local pathologists as pure seminoma, two as teratoma differentiated, 20 as malignant teratoma intermediate, 16 as malignant teratoma undifferentiated, seven have combined seminoma and teratoma histologies and four could only be classified as malignant teratoma without further specification. Altogether, there were 45 right-sided and 41 left-sided tumours and five unilateral tumours where the side was not recorded. Table II summarises the histological classification into two groups, pure seminoma and other germ cell tumours, for the 86 patients and shows the median age at diagnosis for each group. For comparison purposes, similar data are presented for the 781 patients in the case-control study without a family history. The median age at initial diagnosis for the 86 familial cases was 29 years (range 16-51 years). For patients with seminoma, the median age was 32.5 years (range 20-51 years), while for patients with other germ cell tumours it was 26 years (range 16-47 years).
The median age at diagnosis of the 781 non-familial patients, who were all aged between 15 and 49 years, was 32.5 years overall and 35.5 and 28.5 years for patients with seminoma and other germ cell tumours respectively. For both histological categories, therefore, the median age at diagnosis was younger in the familial patients. This difference was statistically significant for those with seminoma and for all histologies combined (P<0.05 and <0.01 respectively, Mann-Whitney test).
The median age at diagnosis of the first tumour in the five familial patients with bilateral cancer was 26.5 years (range 20-33 years) which was younger than in those with unilateral cancer (29.5 years) although the difference was not statistically significant. Two of these five patients with an initial seminoma were diagnosed at 32 and 33 years while three with a teratoma were diagnosed at 20, 22 and 26 years.
In the father-son pairs, the median age at diagnosis in the fathers (34.5 years) was significantly (P<0.01, Mann-Whitney test) older than in the sons (24.5 years) with a mean difference of 13.2 years (range 3-22 years). There were six seminomas in the fathers compared to five in the sons. In the non-twin brother pairs there was no tendency for the elder brother to have a later age at diagnosis than the younger brother and the mean difference in age at diagnosis between all broth. rs (including twins) was 5.5 years (range 1-20 years).
Information about a prior history of UDT was available for 79 individuals and, of these, eight (10.1%) had such a diagnosis which was bilateral in three cases. In four of the five unilateral cases the cancer was diagnosed in the ipsilateral testis. In no family was there more than one case of UDT. All the unilateral cases of UDT underwent orchido- 0:8 C)
. 0 . . Table III , two of these families having been reported previously (Oliver et al., 1986b) . Uncle-nephews have a 50% probability and cousins have a 25% probability of sharing one haplotype. Both uncle-nephew pairs and one of the cousin pairs share one haplotype. Because of the small numbers of these second degree families they could not be combined into a summary statistical analysis.
Discussion
The families reported here add substantially to the literature increasing the total number of reports of familial cases by about 30%. Our best estimate of the proportion of cases that are familial, derived from the case-control study, is 1.5% which is similar to other recent estimates (Tollerud et al., 1985; Dieckmann et al., 1987) . This would indicate that most familial cases are not reported in the literature and that each year there should be about 15 such cases in the UK and 90 in the USA alone (assuming 1,000 and 6,000 new diagnoses per annum in the UK and USA respectively (Cancer Research Campaign, 1990; American Cancer Society, 1990) .
As with other forms of cancer (Anderson, 1975) , familial cases were diagnosed at younger ages than non-familial cases. The non-familial cases from the case-control study were an appropriate group to use for these comparisons because similar standards of histological review were adopted. The case-control study did not, however, recruit cases over the age of 49 years and, as approximately 14% of testicular cancers are diagnosed after this age (OPCS, 1990) , differences between familial and non-familial cases in age at diagnosis are likely to be greater than those reported. Indeed the 13 familial cases from the case-control study had a median age at diagnosis of 28.5 years (28.5 years for nine cases with seminoma and 24 years for four cases with other germ cell tumours) i.e. for each category slightly younger, although not significantly so, than the median age for all familial cases presented in Table II. The difference in age at diagnosis between familial and non-familial cases is unlikely to be due to increased surveillance of families after the first cases had been identified. The median age at diagnosis of the first diagnosed members (who would be free of any surveillance bias) of the 42 families was 26.5 years overall (30.5 years for 17 cases with seminoma and 25.5 years for 25 cases with other germ cell tumours) i.e. not substantially different from the medians of all family cases presented in Table II. There was a substantial difference in age of diagnosis between fathers and sons among the nine pairs in this study and this could indicate 'genetic anticipation' as suggested by Raghavan et al. (1980) ie, the earlier appearance of a genetic condition with increased severity in successive generations. It is, however, likely that selection due to death or infertility of young cases in the paternal generation before they could produce children, could entirely explain this difference.
The presence of bilateral tumours in five of the 86 individ- 1  26  12  1  2  13  31  31  14  2  3  15  2  29  16  1  2  17  26  29  18  24  32  19  2  2   20  3  3  21  3  w68  26  2  3  27  29  w68  29 (Oliver et al., 1986b) (family no 39 now differs from original report of the haplotype) uals (6.0%) was higher than expected from unselected case series where the prevalence is in the order of 2.5% (Dieckmann et al., 1986) . This is analogous to the situation in other paired organs e.g. breast, eye, kidney, in which bilateral disease is more common in familial cases. According to the model for retinoblastoma as proposed by Knudson (1986) , this would be compatible with the occurrence of a germ line mutation in those familial cases which have a genetic predisposition. The bilateral cases did have an earlier age at onset of disease although this comparison, based on only five patients with bilateral disease, was not statistically significant.
The prevalence of UDT in these familial cases (10%) was no different from that recorded in other case series where the prevalence is usually between 8 and 10% (Chilvers & Pike, 1989) . Thus although UDT is a major risk factor for testicular cancer (Chilvers & Pike, 1989) , there is no evidence from these data that it has a stronger association with familial forms of the disease. Similarly a history of infantile inguinal hernia did not seem to be more common in these familial cases compared with non-familial cases (Swerdlow et al., 1987) . It was not possible to estimate whether other urogenital abnormalities in the affected cases or their relatives were specifically associated with familial testicular cancer as has been reported previously (Tollerud et al., 1985) . There were, however, specific families with a remarkably high prevalence of such abnormalities in combination with familial cancer. An example is family number 10 where there were three brothers with testicular cancer, a fourth who was hypogonadol and a fifth who was infertile.
Our risk estimate for the likelihood of developing testicular cancer if a brother had already been affected was 8.0 in comparison with a matched control group and, using actuarial methods, 9.8 in comparison with national registration rates. The precision of the latter estimate was considerably greater, reflected in the much narrower confidence intervals, and the analysis on which it was based adequately takes into account the period of time for which each brother was at risk, the case with two affected brothers (family no. 7) and the double-ascertained family (no. 8). A case-control comparison could also be biased in that controls may be less likely to know about or to remember cancer diagnoses in their brothers. A problem with using cancer registration rates for comparison of the actuarial risk is that there may be some routine under-reporting to cancer registries (Swerdlow, 1986) . For this reason we only made use of the latest available rates (for 1985) rather than earlier years for which under-reporting would be more extensive. Also, under-reporting is likely to occur less frequently in young and middleaged men with testicular cancer who are of intense clinical interest. For these reasons, we believe that the extent of under-reporting would be no more than 10%. Under-report-I ing will be partly offset by the fact that secular rates of testicular cancer have been increasing (Forman, 1989) (Easton & Peto, 1990 ) and similar to that for a history of UDT (for which the risk is about 5-fold (Chilvers & Pike, 1989) Having established a strong familial association, the question arises of the extent to which this is a result of genetic susceptibility. The marked racial differences in the incidence of testicular cancer (Forman, 1989) , the lack of change in incidence in migrant groups (Muir et al., 1987) and the high risk of testicular cancer associated with certain congenital disorders of sexual differentiation (Verp & Simpson, 1987; Savage & Lowe, 1990) all lend support to the possibility of a genetic component. There have been several HLA phenotyping studies of unselected patients with testicular cancer (De Wolf et al., 1979; Majsky, 1979; Pollack et al., 1982; Oliver et al., 1986a; Dieckmann & Keyserlingk, 1988; Kratzick et al., 1989 ) and, although not entirely consistent in their results, they have hinted at an association between cancer risk and specific antigens brought about by genetic disequilibrium. This association would indicate a linkage between a candidate predisposition gene and the HLA complex on chromosome 6. Anecdotal reports (Pollack et al., 1982; Tollerud et al., 1985; Kandel et al., 1988; Hayakawa et aL., 1986; Oliver et al., 1986b; Natsume et al., 1989; Dieckmann & Keyserlingk, 1989 ) of a higher than expected level of HLA haplotype sharing between affected familial cases lend support to this hypothesis.
The sib-pair analysis (Haseman & Elston, 1972; Thomson & Bodmer, 1976 ) is a powerful tool to investigate genetic linkage in this type of situation where extensive pedigrees are not available. The method has been used successfully in studies of a similar size to this one to look at the association between HLA and both Hodgkin's disease (Hors et al., 1984) and nasopharyngeal carcinoma (Lu et al., 1990) .
Our analysis, based on 21 sib-pairs, shows that the level of association with testicular cancer was no higher than that expected by random segregation. This was so despite the assumption of maximum possible sharing in families where there was ambiguity about the number of haplotypes shared. Combining the 21 pairs with the ten reported previously in the literature resulted in four, 21 and six pairs sharing 0, 1 and 2 haplotypes compared with expected numbers of 7.75, 15.5 and 7.75 for which the chi-square (4.16) is non-significant. The lack of association in our 21 pairs remained after sub-dividing sib-pairs into different histological categories, i.e., sib-pairs with only seminoma or only other germ cell tumour histologies. There was also no difference in either histological type or age at disease onset between those sibpairs that shared two haplotypes and those that shared one or none. It is, therefore, unlikely that there is a major gene associated with testicular cancer predisposition within or linked to the major histocompatability complex. However as class II typing has not been performed we cannot formally exclude an association with class II loci that is not detectable by linkage to class I loci, similar to the situation in Hodgkin's disease (Bodmer et al., 1989) . In addition there remains the possibility that HLA type might have prognostic significance once the disease has developed (Oliver et al., 1986a) . We are currently investigating linkage with loci on other chromosomes.
